Call Us For A Consultation At (310) 286 2800


Archive: Author: LA IVF

Blastocyst (Day 5) Transfer

Over the years, blastocyst transfer (BT) or Day 5 transfer has become increasing prevalent among IVF programs and transfer of good quality blastocysts is associated with high rate of implantation/pregnancy and low rate of multiple pregnancy. Using advanced reproductive technologies (ART), multiple mature eggs can now be recovered from a woman in a single cycle. […]

Read More

Reproductive Age and Fertility Outcome

Women are born with a finite number of eggs (1-2 million in both ovaries at birth) and at the time of puberty the total number decreases to approximately 500,000. At age 37, there are approximately 25,000 eggs left in the ovaries and less than 500 at the time of menopause. A monthly process of using […]

Read More

An Alternative IVF Protocol: The GnRH Agonist/Antagonist Conversion Protocol

The agonist antagonist conversion protocol refers to a switch in the pituitary suppression drugs during an IVF cycle. We now know that some form of pituitary blockade, either in the form of a GnRH agonist (e.g. Lupron, Buserelin, Nafarelin, and Synarel) or a GnRH antagonist (e.g. Cetrorelix, and Ganirelix) is an essential component in ovarian […]

Read More

H1N1 (Swine) Flu, Flu Vaccine and Pregnancy

H1N1 flu (a.k.a. swine flu) has affected many pregnant and non-pregnant women and the management of such cases including vaccination has created concerns and confusion in the general population. Swine flu is most commonly caused by swine influenza virus A and one of its subtypes called H1N1. It is relatively common in pigs and was […]

Read More

Embryo Transfer on Day 3 Versus Day 5

The concept of blastocyst transfer (BT) is not new to the field of Assisted Reproduction. There have been reports of BT pregnancies in humans as early as 1990, and even earlier in animals. However, the ability to consistently produce a high percentage of blastocysts from cultured embryos is a relatively recent development. The freshly fertilized […]

Read More

Fertility Preservation for Cancer Patients

Patients diagnosed with cancer are typically planned to undergo surgery, chemotherapy or radiation depending on the location and the type of the cancer. In some cases, a combination of these treatment options may be applicable during a time period and in most cases urgent treatment is necessary. Therefore, an immediate consultation with a fertility specialist […]

Read More

Abnormal Number of Chromosomes (Aneuploidy)

Each cell in the body should have 46 chromosomes including the cells in a developing embryo. 23 chromosomes are present in a chromosomally normal egg and the normal sperm brings 23 additional chromosomes to make 46 in total. In cases of poor sperm or poor egg quality, number of chromosomes in each cell of the […]

Read More


Approximately one-third of American adults are obese and 62% of American women are either overweight or obese. More than 15% of the US population face increased health risks because of obesity. These include hypertension, dyslipidemia (high total cholesterol or high levels of triglycerides), type 2 diabetes, coronary heart disease, stroke, gallbladder disease osteoarthritis, sleep apnea […]

Read More

Clomid Challenge Test

In order to evaluate ovarian function or ovarian reserve, clomiphene citrate challenge test (CCCT) has been used in fertility practice over the years. CCCT can better predict individual response to ovarian stimulation compared to FSH test alone and may be used to help determine the treatment protocol. In controlled ovarian stimulation cycles, this test can […]

Read More


Adenomyosis is defined as the presence of endometrial glands and stroma in the myometrium (muscle layer) of the uterus. It can be localized or diffuse (involving most of the uterus) and more commonly observed in parous women between the ages of 35-50. The exact cause of adenomyosis is unknown and may resemble fibroids on ultrasound, […]

Read More

TEL: 310-286-2800 | FAX: 310-691-1116